Memphasys Secures CE Mark Approval for Felix System
Filed with ASX · · 4 pages · English
• CE Mark approval achieved for the Felix™ System under EU MDR, unlocking full commercial deployment across Europe and other CE-recognised international markets. • Immediate Access to ~A$50+ million (€29+ million) Felix™ Addressable Market • Binding, multi-year commercial agreements now activated, including: o a five-year European commercial agreement with CFA Italia valued at a minimum of ~A$925,
Story so far
Earlier from Memphasys
- Memphasys Secures Long-Term European Supply Agreement
- Key MENA Partner Secures Early Felix Cartridge Order
- Memphasys Implements Leadership Restructure
- Felix Middle East Direct Sales Strategy
- Completion of Entitlement Offer
Later from Memphasys
- Placement of Shortfall Securities from the Entitlement Offer
- Memphasys Extends Convertible Note Repayment Terms
- Qatar's largest IVF Institution Places MENA Orders for Felix
- Regulatory Submissions Lodged for Felix
- Trading Halt
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys